Recent studies examine potential delays to COVID vaccine updates, variability in pediatric antiviral use, the impact of SARS-CoV-2 on sperm quality, and menstrual cycle changes following vaccination.
The FDA has announced that it will limit access to COVID-19 vaccines, making them only available to high-risk populations. The organization also announced that they will require manufacturers to further...
A 2-year follow-up of the COVAXID trial shows that repeated SARS-CoV-2 mRNA booster doses significantly improve antibody and T cell responses in immunocompromised patients, even among initial poor...
A population-based cohort study found that receiving two or more doses of a COVID-19 vaccine was associated with a significantly lower risk of developing persistent post–COVID condition among individuals...
A recent study examined how prior SARS-CoV-2 vaccination influences innate and adaptive immune responses in breakthrough infections, revealing distinct immune activation patterns.
This respiratory health update covers rising influenza deaths, the spread of new SARS-CoV-2 variants, shifting reinfection patterns, and cardiovascular risks in children
In this respiratory diseases roundup, researchers examine COVID-19 protection, hospitalization rates, long COVID predictors, and rare disease mortality risks.
In this respiratory disease roundup, experts examine the rising cases of human metapneumovirus in China, new research on COVID-19’s long-term effects on kidney function, the effectiveness of...
In this respiratory disease roundup, experts discuss the rising concerns over new cases of avian influenza in young people, the FDA's emergency approval of pemivibart monoclonal antibody for COVID-19, the...
